Muscle Relaxant Drugs Market Size & Share Report, 2032

Muscle Relaxant Drugs Market - By Drug Type (Skeletal Muscle Relaxant Drugs), Dosage Form (Tablet, Capsule), Application (Muscle Spasm & Pain Relief), Route of Administration (Oral), Distribution Channel (Hospital Pharmacy), Global Forecast 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast calculation

1.4&nbsp;&nbsp;&nbsp; Covid-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global muscle relaxant drugs market 3600&nbsp;synopsis, 2018 &ndash; 2032 (USD Million)

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Region trends

2.1.3&nbsp;&nbsp;&nbsp; Drug type trends

2.1.4&nbsp;&nbsp;&nbsp; Dosage form trends

2.1.5&nbsp;&nbsp;&nbsp; Application trends

2.1.6&nbsp;&nbsp;&nbsp; Route of administration trends

2.1.7&nbsp;&nbsp;&nbsp; Distribution channel trends

Chapter 3&nbsp;&nbsp;&nbsp;Muscle Relaxant Drugs Market Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing geriatric population coupled with chronic diseases

3.2.1.2&nbsp;&nbsp;&nbsp;Increasing prevalence of musculoskeletal disorders

3.2.1.3&nbsp;&nbsp;&nbsp;Growing advancement in drug development

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Side-effects associated with muscle relaxants

3.2.2.2&nbsp;&nbsp;&nbsp;Strict regulatory norms

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By drug type

3.3.2&nbsp;&nbsp;&nbsp; By dosage form

3.3.3&nbsp;&nbsp;&nbsp; By application

3.3.4&nbsp;&nbsp;&nbsp; By route of administration

3.3.5&nbsp;&nbsp;&nbsp; By distribution channel

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.5&nbsp;&nbsp;&nbsp; Strategic dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Muscle Relaxant Drugs Market Estimates and Forecast, By Drug Type, 2018 - 2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by drug type

5.2&nbsp;&nbsp;&nbsp; Skeletal muscle relaxant drugs

5.3&nbsp;&nbsp;&nbsp; Neuromuscular blocking agents

5.4&nbsp;&nbsp;&nbsp; Facial muscle relaxant drugs

Chapter 6&nbsp;&nbsp;&nbsp;Muscle Relaxant Drugs Market Estimates and Forecast, By Dosage Form, 2018 - 2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by dosage form

6.2&nbsp;&nbsp;&nbsp; Tablet

6.3&nbsp;&nbsp;&nbsp; Capsule

6.4&nbsp;&nbsp;&nbsp; Liquid

6.5&nbsp;&nbsp;&nbsp; Gel, ointments &amp; sprays

Chapter 7&nbsp;&nbsp;&nbsp;Muscle Relaxant Drugs Market Estimates and Forecast, By Application, 2018 - 2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by application

7.2&nbsp;&nbsp;&nbsp; Muscle spasm &amp; pain relief

7.3&nbsp;&nbsp;&nbsp; Musculoskeletal disorders

7.4&nbsp;&nbsp;&nbsp; Surgery

7.5&nbsp;&nbsp;&nbsp; Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Muscle Relaxant Drugs Market Estimates and Forecast, By Route of Administration, 2018 - 2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by route of administration

8.2&nbsp;&nbsp;&nbsp; Oral

8.3&nbsp;&nbsp;&nbsp; Parenteral

8.4&nbsp;&nbsp;&nbsp; Topical

Chapter 9&nbsp;&nbsp;&nbsp;Muscle Relaxant Drugs Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)

9.1&nbsp;&nbsp;&nbsp; Key trends, by distribution channel

9.2&nbsp;&nbsp;&nbsp; Hospital pharmacy

9.3&nbsp;&nbsp;&nbsp; Specialty &amp; Retail pharmacy

9.4&nbsp;&nbsp;&nbsp; Online pharmacy

Chapter 10&nbsp;&nbsp;&nbsp;Muscle Relaxant Drugs Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

10.1&nbsp;&nbsp;&nbsp; Key trends, by region

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp; U.S.

10.2.2&nbsp;&nbsp;&nbsp; Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp; Germany

10.3.2&nbsp;&nbsp;&nbsp; UK

10.3.3&nbsp;&nbsp;&nbsp; France

10.3.4&nbsp;&nbsp;&nbsp; Spain

10.3.5&nbsp;&nbsp;&nbsp; Italy

10.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp; China

10.4.2&nbsp;&nbsp;&nbsp; Japan

10.4.3&nbsp;&nbsp;&nbsp; India

10.4.4&nbsp;&nbsp;&nbsp; Australia

10.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp; Brazil

10.5.2&nbsp;&nbsp;&nbsp; Mexico

10.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

10.6.1&nbsp;&nbsp;&nbsp; South Africa

10.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Amneal Pharmaceuticals LLC

11.2&nbsp;&nbsp;&nbsp; Ipsen Biopharmaceuticals, Inc.

11.3&nbsp;&nbsp;&nbsp; Merz Pharmaceuticals, LLC.

11.4&nbsp;&nbsp;&nbsp; Mylan (Viatris)

11.5&nbsp;&nbsp;&nbsp; Sanofi

11.6&nbsp;&nbsp;&nbsp; Pfizer Inc

11.7&nbsp;&nbsp;&nbsp; Novartis AG

11.8&nbsp;&nbsp;&nbsp; Teva Pharmaceuticals Industries Ltd, Inc.

11.9&nbsp;&nbsp;&nbsp; Vertical Pharmaceuticals

11.10&nbsp;&nbsp;&nbsp; Sun Pharmaceutical Industries Ltd.

11.11&nbsp;&nbsp;&nbsp; SteriMax Inc

11.12&nbsp;&nbsp;&nbsp; Par Pharmaceutical

11.13&nbsp;&nbsp;&nbsp; Abbott Laboratories

11.14&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche AG 
&nbsp;

Muscle Relaxant Drugs Market

Inquiry Before Buying